Nuclear Imaging

Molecular Imaging

Nuclear Imaging

August 5, 2014 — GE Healthcare announced the first integrated, simultaneous, time-of-flight (TOF) capable, whole-body Signa PET/MR (positron emission tomography/magnetic resonance) is 510(k) pending at the U.S. Food and Drug Administration (FDA)....

Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent called Tc-99m filtered sulfur colloid when undergoing lymphoscintigraphy, a functional imaging techni...

The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon emission computed tomography (SPECT). 

GE Healthcare received U.S. Food and Drug Administration (FDA) 510(k) clearance of its Q.Clear technology, which is designed to provide up to two times improvement in both quantitative accuracy and image quality in PET/CT imaging. 

September 16, 2014 — Advanced Accelerator Applications (AAA), an international specialist in molecular nuclear medicine, announced this week it has entered...
September 2, 2014 — GE Healthcare announced that the Vizamyl flutemetamol (18F) solution for injection has received marketing authorization from the European...
Kit Lam and colleagues from UC Davis and other institutions have created dynamic nanoparticles (NPs) that could provide an arsenal of applications to diagnose...
August 27, 2014 — Telik Inc., a clinical stage oncology drug development company that merged with MabVax Therapeutics Inc. on July 8, announced it has...
Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept) injection is a radioactive diagnostic imaging agent, approved by the
Siemens Healthcare's syngo.via for molecular imaging is a reading solution that transforms large amounts of data into comprehensive results...
GE Healthcare's Discovery* IQ^ PET/CT (positron emission tomography/computed tomography) system enable both outstanding image quality and...

Articles

August 5, 2014 — GE Healthcare announced the first integrated, simultaneous, time-of-flight (TOF) capable, whole-body Signa PET/MR (positron emission...
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recently held its annual meeting in St. Louis. It provided an in-depth review of molecular...
A simple noninvasive blood test matched with state-of-the-art molecular imaging of individual cells could help oncologists understand their patients’ chances...
Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent called Tc-99m...

Video Center

As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
2 weeks 14 hours ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
7 weeks 5 days ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
10 weeks 6 days ago
This webinar explores the role of modern imaging modalities, especially MRI, in all steps of interstitial brachytherapy. It defines the role of imaging in...
This webinar explains more about the breast imaging application available with GE Healthcare's unified Web-based viewer. Available applications and...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...